Pacific Biosciences's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Pacific Biosciences (NASDAQ:PACB) is set to release its latest quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $-0.32. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $7.15, down 13.57% over the last 52-week period.
October 27, 2023 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pacific Biosciences is expected to report an EPS of $-0.32 in its upcoming earnings. The stock has been down 13.57% over the last year.
The company's stock has been on a downward trend over the past year, which could be a concern for investors. The estimated negative EPS for the upcoming earnings also indicates potential financial struggles. However, the company's past performance shows that the earnings release can have a mixed impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100